HeartSciences (HSCSW) Net Equity Issued and Repurchased (2022 - 2025)

HeartSciences (HSCSW) has reported Net Equity Issued and Repurchased for 4 consecutive years, with $171276.0 the latest figure, recorded in Q2 2025.

• For the quarter ending Q2 2025, Net Equity Issued and Repurchased changed N/A year-over-year to $171276.0; the trailing twelve-month figure through Apr 2026 stood at $801276.0 (down 49.96% YoY), and the FY2026 full-year result was $172839.0, down 84.94% from the prior year.
• Net Equity Issued and Repurchased eased to $171276.0 in Q2 2025 per HSCSW's latest filing, from $369000.0 in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $5.2 million in Q3 2022 and bottomed at $171276.0 in Q2 2025.
• Historically, Net Equity Issued and Repurchased has averaged $1.4 million across 4 years, with a median of $630000.0 in 2023.
• The sharpest annual moves came in 2023 and 2024: Net Equity Issued and Repurchased plunged 84.6% in 2023, then sank 53.88% in 2024.
• Over 4 years, Net Equity Issued and Repurchased stood at $5.2 million in 2022, then sank by 87.87% to $630000.0 in 2023, then plunged by 41.43% to $369000.0 in 2024, then sank by 53.58% to $171276.0 in 2025.
• According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $171276.0, $369000.0, and $630000.0 for Q2 2025, Q3 2024, and Q4 2023 respectively.